发布于: Android转发:0回复:0喜欢:0

Novartis to strengthen oncology pipeline with agreement to acquire MorphoSys AG for EUR 68 per share or an aggregate of EUR 2.7bn in cash 。27亿欧元$诺华制药(NVS)$ $MorphoSys(MOR)$